Zhuofei Bi

916 citations
21 papers · 648 indexed · h-index 12
Topics
Cancer-related molecular mechanisms research (5 papers)MicroRNA in disease regulation (3 papers)Breast Cancer Treatment Studies (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Zhuofei Bi

21 papers receiving 638 citations

Peers

Zhuofei Bi
Comparison fields: 5 of 69
  • Molecular Biology 391
  • Cancer Research 389
  • Oncology 174
  • Pulmonary and Respiratory Medicine 82
  • Surgery 66
Replace Huaixin Xing with:
Huaixin Xing China
Shengling Fu China
Guohong Song China
Wen Peng China
Debbie Hege Svendsrud Norway
Hongjian Yang China
Danielle Braggio United States
Leping Yang China
Ya‐Ching Lu Taiwan
Xinguo Zhu China
Zhuofei Bi relative to Huaixin Xing China Huaixin Xing's profile →
Citations per field
00.5×1.5×2.2×
Huaixin Xing · 1×
Citations per year

Countries citing papers authored by Zhuofei Bi

Since Specialization
Citations

This map shows the geographic impact of Zhuofei Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuofei Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuofei Bi more than expected).

Fields of papers citing papers by Zhuofei Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuofei Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuofei Bi. The network helps show where Zhuofei Bi may publish in the future.

Co-authorship network of co-authors of Zhuofei Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuofei Bi. A scholar is included among the top collaborators of Zhuofei Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuofei Bi. Zhuofei Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 1
3 15
4 1
5 2
6 137
7 3
8 26
9 73
10 10
11 9
12 13
13 52
14 59
15 3
16 57
17
[Whole brain radiation therapy plus temozolomide in the treatment of brain metastases from non small cell lung cancer: a meta-analysis].
5
18 16
19 22
20 30

About Zhuofei Bi

Zhuofei Bi is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 21 papers that have together received 648 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cancer Research (389 citations), Oncology (174 citations) and Molecular Biology (391 citations). Zhuofei Bi has collaborated with scholars based in China and United States. Frequent co-authors include Yimin Liu, Xiaohui Zhao, Herui Yao, Yanhui Jiang, Kaiyun You, Wei Wu, Shangyou Zheng, Liting Li, Zhihua Li and Yandan Yao. Their work appears in journals such as Nature Communications, Advanced Science and World Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026